Pavel Drevinek
Overview
Explore the profile of Pavel Drevinek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
3342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boattini M, Bianco G, Bastos P, Mavromanolaki V, Maraki S, Spiliopoulou A, et al.
Int J Antimicrob Agents
. 2025 Mar;
:107478.
PMID: 40024606
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe. Methods: We conducted a multicentre...
2.
Smelikova E, Krutova M, capek V, Brajerova M, Drevinek P, Tkadlec J
Ecotoxicol Environ Saf
. 2025 Jan;
289():117624.
PMID: 39752915
Public transport represents a potential site for the transmission of resistant pathogens due to the rapid movement of large numbers of people. This study aimed to investigate the bacterial contamination...
3.
Plankaova A, Brajerova M, capek V, Novotna G, Kinross P, Skalova J, et al.
Int J Antimicrob Agents
. 2024 Dec;
65(1):107408.
PMID: 39721912
No abstract available.
4.
Cinek O, Furstova E, Novotna S, Hubackova K, Dousova T, Borek-Dohalska L, et al.
J Cyst Fibros
. 2024 Sep;
24(1):157-163.
PMID: 39278758
The forskolin-induced swelling assay (FIS) in patient-derived intestinal organoids (PDIOs), used to determine in vitro responsiveness to elexacaftor/tezacaftor/ivacaftor (ETI), showed variability in swelling among PDIOs obtained from people with CF...
5.
Gramegna A, Addy C, Allen L, Bakkeheim E, Brown C, Daniels T, et al.
J Cyst Fibros
. 2024 May;
23(3):375-387.
PMID: 38789317
This is the final of four papers updating standards for the care of people with CF. That this paper "Planning a longer life" was considered necessary, highlights how much CF...
6.
Burgel P, Ballmann M, Drevinek P, Heijerman H, Jung A, Mainz J, et al.
BMJ Open Respir Res
. 2024 May;
11(1).
PMID: 38702073
The major cause of mortality in people with cystic fibrosis (pwCF) is progressive lung disease characterised by acute and chronic infections, the accumulation of mucus, airway inflammation, structural damage and...
7.
Kantor J, Tkadlec J, Hurych J, Vaculova M, Antuskova M, Lzicarova D, et al.
Folia Microbiol (Praha)
. 2024 Apr;
69(3):693-696.
PMID: 38625660
Following the COVID-19 infection, the sternum dislocation and wound dehiscence resulted in an infection complicating the recovery of an immunosuppressed patient after bilateral lung transplantation. Anaerobic culture (96 h) of...
8.
Drevinek P, Flisiak R, Nemes R, Nogales Crespo K, Tomasiewicz K
Diagnostics (Basel)
. 2024 Mar;
14(6).
PMID: 38535051
This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and...
9.
Furstova E, Drevinek P, Novotna S, Libik M, Benesova K, Borek-Dohalska L, et al.
Eur Respir J
. 2024 Mar;
63(4).
PMID: 38485147
No abstract available.
10.
Burgel P, Southern K, Addy C, Battezzati A, Berry C, Bouchara J, et al.
J Cyst Fibros
. 2024 Jan;
23(2):187-202.
PMID: 38233247
This is the third in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on recognising...